Analytical Data
-
基因名
SLC36A2
- Application
-
别名
SLC36A2; PAT2; TRAMD1; Proton-coupled amino acid transporter 2; Proton/amino acid transporter 2; Solute carrier family 36 member 2; Tramdorin-1
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q495M3
-
表达区间
1-285 aa
-
氨基酸序列
MDSRLYMLSFLPFLVLLVLIRNLRILTIFSMLANISMLVSLVIIIQYITQEIPDPSRLPLVASWKTYPLFFGTAIFSFESIGVVLPLENKMKNARHFPAILSLGMSIVTSLYIGMAALGYLRFGDDIKASISLNLPNCWLYQSVKLLYIAGILCTYALQFYVPAEIIIPFAISRVSTRWALPLDLSIRLVMVCLTCLLAILIPRLDLVISLVGSVSGTALALIIPPLLEVTTFYSEGMSPLTIFKDALISILGFVGFVVGTYQALDELLKSEDSHPFSNSTTFVR
-
分子量
58 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SLC36A2, a member of the solute carrier family, encodes a proton-coupled amino acid transporter primarily involved in the absorption of neutral amino acids in the intestine and their reabsorption in the kidneys. Its significance is underscored by its association with human health, particularly in cases of neurological disorders linked to amino acid imbalances. Recent studies have highlighted SLC36A2's role in neurotransmitter regulation, affecting conditions such as autism spectrum disorders and developmental delays. Understanding its structure and function through the generation and analysis of recombinant SLC36A2 protein can provide vital insights into its transport mechanisms and physiological roles. Such research is crucial for developing therapeutic strategies targeting amino acid transport dysregulation in various diseases. Moreover, investigating the functional dynamics of this protein can unveil potential interactions with pharmacological agents, thereby enhancing our comprehension of its contribution to cellular homeostasis and overall metabolic health. Therefore, the study of SLC36A2 recombinant protein becomes essential for both elucidating fundamental biological processes and informing clinical approaches to related disorders.
